Report cover image

Monoclonal Antibody Market, By Source Type, By Production Types, By Indication, By End-User, By Country, and By Region – Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Publisher AnalystView Market Insights
Published Jul 04, 2025
Length 301 Pages
SKU # ANVM20892849

Description

REPORT HIGHLIGHT

The Monoclonal Antibody Market size was valued at US$ 250.28 Million in 2024, expanding at a CAGR of 11.92% from 2025 to 2032.

The Monoclonal Antibody Market refers to the sector involved in the development and commercialization of antibodies engineered to target specific antigens, primarily used in diagnostics, therapeutics, and research applications. The increasing prevalence of chronic diseases like cancer and autoimmune disorders has significantly accelerated demand, with over 70% of biologic therapies in development focusing on monoclonal antibodies. However, high production costs and complex manufacturing processes often limit accessibility, posing challenges for widespread adoption. Advances in bioengineering and personalized medicine present substantial opportunities, enabling the development of more effective and tailored treatments. Additionally, the rising number of clinical trials utilizing monoclonal antibodies, which accounted for nearly 500 ongoing studies globally last year, highlights the expanding scope of this market segment. Despite hurdles, expanding applications in oncology, immunology, and infectious diseases continue to offer promising growth avenues.

Monoclonal Antibody Market- Market Dynamics
Rising prevalence of chronic diseases and advances in bioengineering to accelerate monoclonal antibody market growth

Rising prevalence of chronic diseases such as cancer and autoimmune disorders has intensified the focus on monoclonal antibody therapies, with the World Health Organization reporting that cancer accounted for nearly 10 million deaths worldwide in recent years. Breakthroughs in bioengineering have enabled more precise targeting of disease mechanisms, improving treatment efficacy and patient outcomes. For instance, the U.S. Food and Drug Administration (FDA) approved over 20 monoclonal antibody-based drugs in the past five years alone, reflecting the growing trust in these therapies. Additionally, initiatives by institutions like the National Institutes of Health (NIH) have boosted research funding for biologics, supporting innovative clinical trials and expanding the therapeutic applications of monoclonal antibodies across various chronic and infectious diseases.

Monoclonal Antibody Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 11.92% over the forecast period (2025-2032)
Based on Source Type segmentation, humanized monoclonal antibodies were predicted to show maximum market share in the year 2024
Based on Production Types segmentation, in vitro was the leading Production Type in 2024
Based on Indication segmentation, Cancer leading was the leading Indication in 2024
On the basis of region, North America was the leading revenue generator in 2024

Monoclonal Antibody Market- Segmentation Analysis:

The Global Monoclonal Antibody Market is segmented on the basis of Source Type, Production Types, Indication, End-User, and Region.

The market is divided into four categories based on Source Type: Murine Monoclonal Antibodies, Chimeric Monoclonal Antibodies, Humanized Monoclonal Antibodies, and Fully Human Monoclonal Antibodies. Humanized monoclonal antibodies dominate due to reduced immunogenicity and improved patient tolerance, followed by fully human antibodies prized for their safety profiles. Chimeric antibodies offer effective targeting but higher immune response risk, while murine antibodies see limited use due to immunogenicity concerns.

The market is divided into two categories based on Production Types: In Vivo and In Vitro. In vitro production leads the market due to greater control, scalability, and consistency in manufacturing monoclonal antibodies, while in vivo methods are less common, primarily used for specific research purposes despite being more time-consuming and less efficient for large-scale production.

Monoclonal Antibody Market- Geographical Insights

The Monoclonal Antibody Market exhibits significant geographical variation driven by regional healthcare infrastructure, regulatory support, and disease prevalence. North America remains a prominent region due to strong funding from government agencies like the National Cancer Institute and advanced biopharmaceutical research facilities, facilitating rapid approval and adoption of monoclonal antibody therapies. Europe follows closely, supported by initiatives from the European Medicines Agency (EMA) and increasing investments in personalized medicine. In Asia-Pacific, rising incidences of chronic diseases coupled with improving healthcare systems in countries such as China, Japan, and India are fueling demand, while government programs aimed at enhancing access to biologics are gaining momentum. Emerging markets in Latin America and the Middle East are also witnessing gradual growth, driven by expanding healthcare coverage and growing awareness about targeted therapies. However, disparities in affordability and availability remain challenges in some regions, influencing the pace of market expansion globally.

Monoclonal Antibody Market- Competitive Landscape:

The competitive landscape of the Monoclonal Antibody Market is characterized by the presence of several leading biopharmaceutical companies investing heavily in research and development to innovate and expand their product portfolios. Major players often collaborate with academic institutions and government research bodies to accelerate the development of novel therapies. Companies focus on differentiating themselves through advances in antibody engineering, such as bispecific antibodies and antibody-drug conjugates, to address unmet medical needs. Regulatory approvals from authorities like the FDA and EMA are critical milestones that influence competitive positioning. Additionally, partnerships and licensing agreements enable faster market entry and geographic expansion. With increasing competition, companies are also working on improving manufacturing efficiencies and reducing production costs to make treatments more accessible. The emphasis on personalized medicine and immunotherapy continues to drive strategic investments, fostering a dynamic and evolving competitive environment.

Recent Developments:

In September 2023, KBI Biopharma has launched SureMAB™, a new monoclonal antibody development platform. SureMAB™ accelerates the discovery and production of high-quality monoclonal antibodies, offering streamlined workflows and reduced timelines for clients developing novel biologic therapeutics across various disease areas.
In April 2025, the FDA announced a phased plan to replace animal testing requirements for monoclonal antibodies and other drugs with advanced, human-relevant methods like AI modeling and organoid testing, aiming to improve safety, accelerate development, and reduce drug costs and animal use.
In March 2024, Roche Pharma India launched Vabysmo (faricimab), the world’s first bispecific monoclonal antibody, for treating neovascular age-related macular degeneration and diabetic macular edema. Vabysmo uniquely targets two disease pathways, offering improved vision outcomes and extended treatment intervals for Indian patients.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MONOCLONAL ANTIBODY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

AbbVie

Alexion Pharmaceuticals

Amgen

Bayer Healthcare

Biogen

Bristol-Myers Squibb

Celltrion

Eli Lilly

Genentech (Roche subsidiary)

GlaxoSmithKline (GSK)

Johnson & Johnson

Merck & Co.

Novartis

Pfizer

Regeneron Pharmaceuticals

Roche

Samsung Bioepis

Sanofi

Takeda Pharmaceutical

UCB Pharma

Others

GLOBAL MONOCLONAL ANTIBODY MARKET, BY SOURCE TYPE- MARKET ANALYSIS, 2019 - 2032

Murine Monoclonal Antibodies
Chimeric Monoclonal Antibodies
Humanized Monoclonal Antibodies
Fully Human Monoclonal Antibodies

GLOBAL MONOCLONAL ANTIBODY MARKET, BY PRODUCTION TYPES- MARKET ANALYSIS, 2019 - 2032

In Vivo
In Vitro

GLOBAL MONOCLONAL ANTIBODY MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

Cancer
Breast cancer
Colorectal cancer
Lung cancer
Ovarian cancer
Others
Autoimmune Diseases
Inflammatory Diseases
Infectious Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Crohn’s Disease
Others

GLOBAL MONOCLONAL ANTIBODY MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Laboratories
Research Institutes
Pharmaceutical & Biotechnology Companies

GLOBAL MONOCLONAL ANTIBODY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Table of Contents

301 Pages
1. Monoclonal Antibody Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Monoclonal Antibody Market Snippet by Source Type
2.1.2. Monoclonal Antibody Market Snippet by Production Types
2.1.3. Monoclonal Antibody Market Snippet by Indication
2.1.4. Monoclonal Antibody Market Snippet by End-User
2.1.5. Monoclonal Antibody Market Snippet by Country
2.1.6. Monoclonal Antibody Market Snippet by Region
2.2. Competitive Insights
3. Monoclonal Antibody Key Market Trends
3.1. Monoclonal Antibody Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Monoclonal Antibody Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Monoclonal Antibody Market Opportunities
3.4. Monoclonal Antibody Market Future Trends
4. Monoclonal Antibody Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Monoclonal Antibody Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Monoclonal Antibody Market Landscape
6.1. Monoclonal Antibody Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Monoclonal Antibody Market – By Source Type
7.1. Overview
7.1.1. Segment Share Analysis, By Source Type, 2024 & 2032 (%)
7.1.2. Murine Monoclonal Antibodies
7.1.3. Chimeric Monoclonal Antibodies
7.1.4. Humanized Monoclonal Antibodies
7.1.5. Fully Human Monoclonal Antibodies
8. Monoclonal Antibody Market – By Production Types
8.1. Overview
8.1.1. Segment Share Analysis, By Production Types, 2024 & 2032 (%)
8.1.2. In Vivo
8.1.3. In Vitro
9. Monoclonal Antibody Market – By Indication
9.1. Overview
9.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
9.1.2. Cancer
9.1.2.1. Breast cancer
9.1.2.2. Colorectal cancer
9.1.2.3. Lung cancer
9.1.2.4. Ovarian cancer
9.1.2.5. Others
9.1.3. Autoimmune Diseases
9.1.4. Inflammatory Diseases
9.1.5. Infectious Diseases
9.1.6. Rheumatoid Arthritis
9.1.7. Multiple Sclerosis
9.1.8. Psoriasis
9.1.9. Crohn’s Disease
9.1.10. Others
10. Monoclonal Antibody Market – By End-User
10.1. Overview
10.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
10.1.2. Hospitals
10.1.3. Diagnostic Laboratories
10.1.4. Research Institutes
10.1.5. Pharmaceutical & Biotechnology Companies
11. Monoclonal Antibody Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
11.2.1. Overview
11.2.2. Monoclonal Antibody Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.2.4. North America Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.2.5. North America Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.2.6. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Monoclonal Antibody Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.3.17. Rest of Europe
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.3.17.3. Rest of the Europe Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.3.17.4. Rest of the Europe Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.3.17.5. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.3.17.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Monoclonal Antibody Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.4.16. Rest of APAC
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.4.16.3. Rest of APAC Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.4.16.4. Rest of APAC Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.4.16.5. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Monoclonal Antibody Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Monoclonal Antibody Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
11.6.14. Rest of MEA
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
11.6.14.3. Rest of MEA Market Size and Forecast, By Source Type, 2019 - 2032 (US$ Million)
11.6.14.4. Rest of MEA Market Size and Forecast, By Production Types, 2019 - 2032 (US$ Million)
11.6.14.5. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12. Key Vendor Analysis- Monoclonal Antibody Industry
12.1. Competitive Dashboard
12.1.1. Competitive Benchmarking
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. AbbVie
12.2.2. Alexion Pharmaceuticals
12.2.3. Amgen
12.2.4. Bayer Healthcare
12.2.5. Biogen
12.2.6. Bristol-Myers Squibb
12.2.7. Celltrion
12.2.8. Eli Lilly
12.2.9. Genentech (Roche subsidiary)
12.2.10. GlaxoSmithKline (GSK)
12.2.11. Johnson & Johnson
12.2.12. Merck & Co.
12.2.13. Novartis
12.2.14. Pfizer
12.2.15. Regeneron Pharmaceuticals
12.2.16. Roche
12.2.17. Samsung Bioepis
12.2.18. Sanofi
12.2.19. Takeda Pharmaceutical
12.2.20. UCB Pharma
12.2.21. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us